Malignant Hyperthermia: A Clinical Review

Adv Anesth. 2019 Dec:37:35-51. doi: 10.1016/j.aan.2019.08.003. Epub 2019 Sep 27.

Authors

Kyeong Seon M Kim¹, Robert Scott Kriss¹, Timothy J Tautz²

Affiliations

¹ UC Davis Department of Anesthesiology and Pain Medicine, UC Davis Medical Center, PSSB Suite 1200, Sacramento, CA 95817, USA.
² UC Davis Department of Anesthesiology and Pain Medicine, UC Davis Medical Center, PSSB Suite 1200, Sacramento, CA 95817, USA. Electronic address: tjtautz@ucdavis.edu.

PMID: 31677658
DOI: 10.1016/j.aan.2019.08.003

No abstract available

Keywords: Associated disorders; Genetics; Malignant hyperthermia; Perioperative management; Signs.

Publication types

Review

MeSH terms

Calcium Channels, L-Type / genetics
Calcium-Binding Proteins / genetics
Calsequestrin
Comorbidity
Dantrolene / therapeutic use
Genetic Predisposition to Disease
Humans
Incidence
Malignant Hyperthermia / etiology*
Malignant Hyperthermia / genetics
Malignant Hyperthermia / mortality
Malignant Hyperthermia / therapy*
Mitochondrial Proteins / genetics
Muscle Relaxants, Central / therapeutic use
Perioperative Care / methods*
Prevalence
Ryanodine Receptor Calcium Release Channel / genetics

Substances

CACNA1S protein, human
CASQ1 protein, human
Calcium Channels, L-Type
Calcium-Binding Proteins
Calsequestrin
Mitochondrial Proteins
Muscle Relaxants, Central
RYR1 protein, human
Ryanodine Receptor Calcium Release Channel
Dantrolene